Mountain View, CA, United States of America

Craig Betts

USPTO Granted Patents = 12 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 68(Granted Patents)

Company Filing History:

Clontech Laboratories, Inc.

patents

Years Active: 2016-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454721 - Template switch-based methods for producing a product nucleic acid (2025-10-28),

2. 11884963 - Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same (2024-01-30),

3. 11124828 - Methods for adding adapters to nucleic acids and compositions for practicing the same (2021-09-21),

4. 11001882 - Template switch-based methods for producing a product nucleic acid (2021-05-11),

5. 10988796 - Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same (2021-04-27),

6. 10954510 - Methods for adding adapters to nucleic acids and compositions for practicing the same (2021-03-23),

7. 10941397 - Methods for adding adapters to nucleic acids and compositions for practicing the same (2021-03-09),

8. 10781443 - Methods for adding adapters to nucleic acids and compositions for practicing the same (2020-09-22),

9. 10415087 - Methods for adding adapters to nucleic acids and compositions for practicing the same (2019-09-17),

10. 10150985 - Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same (2018-12-11),

11. 9719136 - Methods for adding adapters to nucleic acids and compositions for practicing the same (2017-08-01),

12. 9410173 - Template switch-based methods for producing a product nucleic acid (2016-08-09),

Title: The Innovative Contributions of Craig Betts

Introduction

Craig Betts is a prominent inventor based in Mountain View, California. He has made significant contributions to the field of molecular biology, particularly in the development of methods for producing nucleic acids. With a total of 12 patents to his name, Betts has established himself as a key figure in the biotechnology industry.

Latest Patents

One of Betts' latest patents is titled "Template switch-based methods for producing a product nucleic acid." This invention provides methods for producing a product nucleic acid by combining template DNA, polymerase, template switch oligonucleotide, and dNTPs into a reaction mixture. The methods ensure that the components are combined under conditions sufficient to produce a product nucleic acid that includes both the template DNA and the template switch oligonucleotide. Another notable patent is focused on "Methods of depleting a target molecule from an initial collection of nucleic acids." This invention outlines methods for depleting a target nucleic acid from an initial collection by using a nucleic acid guided nuclease specific for the target. The methods are designed to cleave or selectively separate the target nucleic acid from the initial collection.

Career Highlights

Throughout his career, Craig Betts has worked with notable companies in the biotechnology sector, including Takara Bio USA, Inc. and Clontech Laboratories, Inc. His work in these organizations has contributed to advancements in genetic research and applications.

Collaborations

Betts has collaborated with several professionals in his field, including Andrew Alan Farmer and Nathalie Bolduc. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Craig Betts is a distinguished inventor whose work has significantly impacted the field of molecular biology. His innovative patents and collaborations reflect his commitment to advancing biotechnology. His contributions continue to influence research and applications in the industry.

This text is generated by artificial intelligence and may not be accurate.